101 – 110 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer
- Contribution to journal › Article
-
Mark
Survival of children with liver tumours in Europe 1978--1989
- Contribution to journal › Article
-
Mark
The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series
- Contribution to journal › Article
-
Mark
Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics
- Contribution to journal › Article
-
Mark
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients
- Contribution to journal › Article
-
Mark
Genetic epidemiology of BRCA1 mutations in Norway
- Contribution to journal › Article
- 2000
-
Mark
Accrual rate-limiting factors in a Swedish randomised ductal carcinoma in situ (DCIS) trial - a demographic study
- Contribution to journal › Article
-
Mark
Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol
- Contribution to journal › Article
-
Mark
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients
- Contribution to journal › Article
-
Mark
Prognosis and clinical presentation of BRCA2-associated breast cancer
- Contribution to journal › Article
